CJ’s incrementally modified drug to be launched from next January
Last June, the Ministry of Food and Drug Safety (MFDS) approved another combination of metformin plus voglibose, a dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes, CJ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
